000			02080 a2200565 4500
005			20250516044115.0
264		0	_c20120126
008			201201s 0 0 eng d
022			_a1601-0825
024	7		_a10.1111/j.1601-0825.2011.01821.x _2doi
040			_aNLM _beng _cNLM
100	1		_aGarming-Legert, K
245	0	0	_aLong-term salivary function after conditioning with busulfan, fractionated or single-dose TBI. _h[electronic resource]
260			_bOral diseases _cOct 2011
300			_a670-6 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAge Factors
650	0	4	_aAnemia, Aplastic _xsurgery
650	0	4	_aArea Under Curve
650	0	4	_aBusulfan _xblood
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDose Fractionation, Radiation
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _xdrug therapy
650	0	4	_aGranulomatous Disease, Chronic _xsurgery
650	0	4	_aHematopoietic Stem Cell Transplantation _xmethods
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xblood
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xsurgery
650	0	4	_aLeukemia, Myeloid, Acute _xsurgery
650	0	4	_aLongitudinal Studies
650	0	4	_aLymphohistiocytosis, Hemophagocytic _xsurgery
650	0	4	_aLymphoma, T-Cell _xsurgery
650	0	4	_aMale
650	0	4	_aMyelodysplastic Syndromes _xsurgery
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xsurgery
650	0	4	_aSalivary Glands _xdrug effects
650	0	4	_aSecretory Rate _xdrug effects
650	0	4	_aSex Factors
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTransplantation, Homologous
650	0	4	_aWhole-Body Irradiation
700	1		_aRemberger, M
700	1		_aRingdén, O
700	1		_aHassan, M
700	1		_aDahllöf, G
773	0		_tOral diseases _gvol. 17 _gno. 7 _gp. 670-6
856	4	0	_uhttps://doi.org/10.1111/j.1601-0825.2011.01821.x _zAvailable from publisher's website
999			_c20971404 _d20971404